Ascent | American Lung Association

Location Select your location

Clinical Trials

Ascent

Institution:

AstraZeneca

Type:

Individual Site

Purpose:

Aclidinium Bromide (Tudorza) which is FDA approved for the maintenance bronchodilator treatment of COPD, including chronic bronchitis and emphysema. Its is administered as a dry powder taken vi an inhaler.

Dates:

February 29, 2016 - February 28, 2019

Disease:

COPD

Register:

http://www.activmedresearch.com/

Contact:

Karina Rosario
978-655-7155
krosario@activmedresearch.com

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.